Use AI/ML to enhance patient classification and understanding of performance and opportunity.
Robust opportunity identification
Leverage patient cohort data to derive conclusions that matter for brands and businesses.
A source of truth for ongoing analytics
Mitigate biases along the patient journey to set real-world claims data as a source of truth for pharma companies.
Enhanced downstream insights
Enriched data enhances segmentation, targeting, KPI tracking, forecasting and much more.
Evaluation of data capture gaps
Estimate capture of various staging, biomarker and drug information to identify the gaps at a national and deeper level.
Advanced AI/ML-based enrichment
Use state-of-the-art machine learning techniques with real-world data sources and domain expertise to mitigate biases from data gaps.
Validation to boost confidence on enrichment
Robust validation techniques including model robustness, business validations and deep desk research ensure insights can be integrated across the board.